Clinical Trial Update: Rezafungin for Treatment of Chronic Pulmonary Aspergillosis (CPA) in Adults With Limited Treatment Options [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rezafungin for chronic pulmonary aspergillosis in adults with limited treatment options; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Aspergillosis

Drugs mentioned

• Rezafungin (rezafungin)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Chronic Pulmonary Aspergillosis | Phase 2 | Status: RECRUITING